Clinical significance of the physicochemical properties of LDL in type 2 diabetes

被引:18
作者
Scheffer, PG
Teerlink, T
Heine, RJ
机构
[1] VU Univ, Med Ctr, Dept Clin Chem, NL-1007 MB Amsterdam, Netherlands
[2] VU Univ, Med Ctr, Dept Endocrinol, Amsterdam, Netherlands
[3] VU Univ, Med Ctr, Cardiovasc Res Inst, Amsterdam, Netherlands
关键词
atherosclerosis; diabetes; LDL; LDL diameter; LDL glycation; LDL oxidation; LDL size;
D O I
10.1007/s00125-005-1736-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is the leading cause of death in type 2 diabetes. LDL cholesterol and atherosclerosis are related, both in healthy people and those with diabetes; however, people with diabetes are more prone to atheroma, even though their LDL cholesterol levels are similar to those in their non-diabetic peers. This is because LDL particles are modified in the presence of diabetes to become more atherogenic. These modifications include glycation in response to high plasma glucose levels; oxidative reactions mediated by increased oxidative stress; and transfer of cholesterol ester, which makes the particles smaller and denser. The latter modification is strongly associated with hypertriglyceridaemia. Oxidatively and non-oxidatively modified LDL is involved in plaque formation, and may thus contribute to the accelerated atherosclerosis. This review discusses the techniques currently used to determine the physicochemical properties of LDL, and examines the evidence that modification of these properties plays a role in the accelerated atherosclerosis associated with type 2 diabetes.
引用
收藏
页码:808 / 816
页数:9
相关论文
共 88 条
[21]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[22]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[23]   A prospective study at coronary heart disease in relation to fasting insulin, glucose, and diabetes - The atherosclerosis risk in communities (ARIC) study [J].
Folsom, AR ;
Szklo, M ;
Stevens, J ;
Liao, FZ ;
Smith, R ;
Eckfeldt, JH .
DIABETES CARE, 1997, 20 (06) :935-942
[24]  
FORTE TM, 1986, METHOD ENZYMOL, V128, P442
[25]  
Gavella M, 2002, DIABETES METAB, V28, P391
[26]  
GRUNDY SM, 1995, CLIN CHEM, V41, P139
[27]   Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes [J].
Gumbiner, B ;
Low, CC ;
Reaven, PD .
DIABETES CARE, 1998, 21 (01) :9-15
[28]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[29]   Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease [J].
Heine, RJ ;
Dekker, JM .
DIABETOLOGIA, 2002, 45 (04) :461-475
[30]   Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease [J].
Holvoet, P ;
Vanhaecke, J ;
Janssens, S ;
Van de Werf, F ;
Collen, D .
CIRCULATION, 1998, 98 (15) :1487-1494